NAD+: Research Chemistry and Literature
Nicotinamide adenine dinucleotide is two nucleotides joined tail to tail. An adenosine monophosphate and a nicotinamide mononucleotide share a pyrophosphate bridge, so the molecule presents an adenine at one end, a nicotinamide at the other, and two ribose rings in between. The adenine half is largely structural. It supplies the binding determinants that Rossmann-fold enzymes recognise. The chemistry happens at the nicotinamide.
That pyridinium ring accepts a hydride at C4 and becomes a 1,4-dihydropyridine. This one event is the whole difference between the two forms. NAD+ is the oxidised member, its ring nitrogen quaternised and positively charged, and it is the species that takes electrons from a substrate. NADH is the reduced member, neutral at that position, and it passes them on. The pair can be told apart by absorbance alone, because only the dihydropyridine absorbs at 340 nm, and a large part of classical enzyme kinetics rests on that single spectroscopic fact.
Reference data
- CAS number
- 53-84-9
- Chemical formula
- C₂₁H₂₇N₇O₁₄P₂
- Molar mass
- 663.43 g/mol
- Shelf life
- 24 months
Origin and identification
Arthur Harden and William John Young found the compound long before anyone could say what it was. Reporting in 1906, they showed that fermentation by cell-free yeast juice stopped when the juice was dialysed and resumed when the dialysate was added back. Whatever crossed the membrane was small, heat-stable and not itself an enzyme. They called it the coferment. Hans von Euler-Chelpin later renamed it cozymase and established that it contained nicotinamide, adenine, ribose and phosphate, while Otto Warburg identified the pyridine ring as the site of hydrogen transfer.
Structure and biosynthesis followed separately. For decades the compound was called diphosphopyridine nucleotide, DPN, which is the name on most literature published before the 1960s. Preiss and Handler traced the route from nicotinic acid through nicotinic acid mononucleotide to the dinucleotide in 1958, and that sequence still carries their names. The salvage arm was mapped much later. Nicotinamide phosphoribosyltransferase recycles the nicotinamide released by NAD-consuming enzymes, and in 2004 Bieganowski and Brenner described nicotinamide riboside kinases as a third entry point independent of the Preiss-Handler route.
Preclinical research context
Few compounds are more deeply embedded in enzyme assay work. Several hundred dehydrogenases use NAD+ as the hydride acceptor, and because the reduced product absorbs at 340 nm while the oxidised form does not, a spectrophotometer set to that wavelength reports catalytic turnover in real time. Substrates with no convenient signal of their own are routinely coupled to a dehydrogenase step for exactly this reason. Lactate, ethanol, glucose-6-phosphate and malate are all quantified this way in ordinary laboratory practice.
A second body of work treats NAD+ as a consumed substrate rather than a recycled cofactor. Imai and colleagues reported in 2000 that the silencing protein Sir2 is a deacetylase requiring NAD+ stoichiometrically, cleaving the glycosidic bond and releasing nicotinamide alongside O-acetyl-ADP-ribose. Sauve and Schramm subsequently resolved the ADP-ribosyl intermediate chemistry that permits it. Poly(ADP-ribose) polymerases had been recognised as consumers far earlier, from the 1963 account by Chambon and colleagues of a nuclear enzyme activated by nicotinamide mononucleotide, and the same substrate logic covers the ADP-ribosyl cyclases and the bacterial ADP-ribosylating toxins. Research across all of these is really research into how one pool is partitioned between competing enzymes.
Neither role tolerates material of unknown content, so NAD+ also functions as an analytical reference material and calibration standard. It anchors the response curves in the UHPLC-MS/MS panels now used to quantify NAD-related metabolites across plasma, whole blood and tissue, it underpins the extinction coefficient checks that validate a coupled assay, and it is the reference against which enzymatic cycling measurements of total dinucleotide are read. Supplying a characterised standard for that work is the basis on which this material is listed.
Analytical characterisation
Purity is measured by reversed-phase HPLC, generally with an ion-pairing modifier or on a polar-endcapped C18, because the free dinucleotide is highly polar and barely retained on a conventional column. An aqueous phosphate or ammonium acetate buffer run against a shallow acetonitrile gradient separates NAD+ from NADH, from nicotinamide mononucleotide and adenosine monophosphate, and from the hydrolysis products that accumulate in stored material. Detection at 260 nm is the working wavelength since both bases absorb there, and a parallel 340 nm channel shows how much reduced form is present.
Identity is confirmed by mass spectrometry. Negative electrospray gives the deprotonated molecule at m/z 662.1 for the monoisotopic free acid, and fragmentation across the pyrophosphate bridge yields the adenosine monophosphate and nicotinamide mononucleotide daughters that establish dinucleotide connectivity. A nicotinamide fragment near m/z 123 in positive mode is the other routine diagnostic. Every lot carries a Certificate of Analysis issued by Janoshik Analytical, giving the chromatographic purity result together with the mass confirmation for that lot.
Handling and storage
NAD+ ships as a white to off-white hygroscopic powder. Hold it sealed and cool, dry over desiccant, and shielded from light. The solid is the durable form and keeps for extended periods under those conditions. Powder that has taken up atmospheric water is the usual reason a lot degrades early, because the hydrolytic reactions that break the pyrophosphate bridge and the nicotinamide glycosidic bond require water to proceed at all. Bring a sealed vial to room temperature before opening so nothing condenses onto cold material.
In aqueous solution the governing constraint is pH, and the window is narrow. NAD+ is comfortable under mildly acidic conditions and decomposes rapidly in alkali, where hydroxide adds to the pyridinium ring to give a set of coloured and fluorescent adducts before the ring opens. Above roughly pH 8 the loss becomes measurable within hours at room temperature. The reduced form behaves in the opposite direction and is destroyed by acid, so a buffer chosen to protect one form will not protect the other, and any assay cycling between them has to sit near neutrality where both survive long enough to be read.
Temperature compounds the same problem. Losses that are slow at 4 degrees Celsius become obvious across a working day at 37, and autoclaving a buffer containing NAD+ destroys it outright, so it belongs in sterile-filtered addition after the medium has cooled. Prepare aqueous stocks fresh, aliquot before freezing so material is thawed once only, and keep them on ice while in use. Standard laboratory personal protective equipment applies. This material is intended for laboratory research use only and is not for human or veterinary use.
References
- The alcoholic ferment of yeast-juice
- Biosynthesis of diphosphopyridine nucleotide. I. Identification of intermediates
- Nicotinamide mononucleotide activation of new DNA-dependent polyadenylic acid synthesizing nuclear enzyme
- Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
- SIR2: the biochemical mechanism of NAD(+)-dependent protein deacetylation and ADP-ribosyl enzyme intermediates
- Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans
- Simultaneous quantification of 26 NAD-related metabolites in plasma, blood, and liver tissue using UHPLC-MS/MS
- Nadide (NAD+), PubChem Compound Summary for CID 5892
Related compounds
This page summarises published laboratory research for reference purposes. Materials described are supplied for in vitro and analytical research use only. Not for human or veterinary consumption.